FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000956748> ?p ?o ?g. }

• W2000956748 endingPage "1842" @default.
• W2000956748 startingPage "1832" @default.
• W2000956748 abstract "γ-L-glutamyl-L-DOPA inhibits Na+-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate.BackgroundFor treatment of phosphate (Pi) overload in various pathophysiological states, an agent that selectively increases renal Pi excretion would be of major value. Previously, we have shown that dopamine (DA) inhibits Na+-Pi cotransport in renal epithelia. However, the administration of DA or its immediate precursor L-DOPA increases DA in multiple tissues. Synthetic dipeptide γ-L-glutamyl-L-DOPA (gludopa) can serve as an inactive precursor (pro-pro-drug) of DA. This study tested the hypothesis that, because of the unique colocalization of γ-glutamyltransferase (γ-GT), aromatic amino acid decarboxylase, Na+-Pi cotransporter, and Na+-L-DOPA cotransporter in brush border membrane (BBM) of proximal tubular cells, gludopa may elicit phosphaturia by action of DA generated within the kidney.MethodsThyroparathyrectomized rats were given placebo, or gludopa, or gludopa + γ-GT inhibitor acivicin. Urinary excretion of Pi, Ca2+, Na+, K+, DA, cAMP, and cGMP was determined, and Na+-Pi cotransport was measured in BBM prepared from kidneys of rats at the end of the experiment.ResultsThe administration of gludopa resulted in: (a) an inhibition of Na+-Pi cotransport, but not cotransport of Na+-proline and Na+-alanine in BBM; (b) an increase (+300%) of fractional excretion (FE) of Pi and a drop (-35%) of plasma Pi, whereas the plasma levels and FEs of Ca2+, Na+, and K+ were unchanged; (c) an increase in urinary excretion of cAMP, but not cGMP; (d) a 1000-fold increase of urinary excretion of DA, without a change in excretion of norepinephrine; and (e) an incubation of gludopa with BBM in vitro, which caused a release of L-DOPA, and the in vivo administration of acivicin, which blocked actions of gludopa to inhibit Na+-Pi cotransport and to increase urinary excretions of Pi and DA.ConclusionsWe conclude that colocalization of enzymes of biotransformation, BBM transporters, and the autocrine/paracrine DA system in cells of proximal tubules constitutes a cellular basis for the potent and specific phosphaturic action of gludopa. γ-L-glutamyl-L-DOPA inhibits Na+-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate. For treatment of phosphate (Pi) overload in various pathophysiological states, an agent that selectively increases renal Pi excretion would be of major value. Previously, we have shown that dopamine (DA) inhibits Na+-Pi cotransport in renal epithelia. However, the administration of DA or its immediate precursor L-DOPA increases DA in multiple tissues. Synthetic dipeptide γ-L-glutamyl-L-DOPA (gludopa) can serve as an inactive precursor (pro-pro-drug) of DA. This study tested the hypothesis that, because of the unique colocalization of γ-glutamyltransferase (γ-GT), aromatic amino acid decarboxylase, Na+-Pi cotransporter, and Na+-L-DOPA cotransporter in brush border membrane (BBM) of proximal tubular cells, gludopa may elicit phosphaturia by action of DA generated within the kidney. Thyroparathyrectomized rats were given placebo, or gludopa, or gludopa + γ-GT inhibitor acivicin. Urinary excretion of Pi, Ca2+, Na+, K+, DA, cAMP, and cGMP was determined, and Na+-Pi cotransport was measured in BBM prepared from kidneys of rats at the end of the experiment. The administration of gludopa resulted in: (a) an inhibition of Na+-Pi cotransport, but not cotransport of Na+-proline and Na+-alanine in BBM; (b) an increase (+300%) of fractional excretion (FE) of Pi and a drop (-35%) of plasma Pi, whereas the plasma levels and FEs of Ca2+, Na+, and K+ were unchanged; (c) an increase in urinary excretion of cAMP, but not cGMP; (d) a 1000-fold increase of urinary excretion of DA, without a change in excretion of norepinephrine; and (e) an incubation of gludopa with BBM in vitro, which caused a release of L-DOPA, and the in vivo administration of acivicin, which blocked actions of gludopa to inhibit Na+-Pi cotransport and to increase urinary excretions of Pi and DA. We conclude that colocalization of enzymes of biotransformation, BBM transporters, and the autocrine/paracrine DA system in cells of proximal tubules constitutes a cellular basis for the potent and specific phosphaturic action of gludopa." @default.
• W2000956748 created "2016-06-24" @default.
• W2000956748 creator A5035803024 @default.
• W2000956748 creator A5055901854 @default.
• W2000956748 creator A5062672488 @default.
• W2000956748 creator A5062819532 @default.
• W2000956748 creator A5064722554 @default.
• W2000956748 date "1999-05-01" @default.
• W2000956748 modified "2023-09-26" @default.
• W2000956748 title "γ-L-glutamyl-L-DOPA inhibits Na+-phosphate cotransport across renal brush border membranes and increases renal excretion of phosphate" @default.
• W2000956748 cites W1573628824 @default.
• W2000956748 cites W1581416262 @default.
• W2000956748 cites W1597035911 @default.
• W2000956748 cites W1657811283 @default.
• W2000956748 cites W1775749144 @default.
• W2000956748 cites W1831705293 @default.
• W2000956748 cites W1965151217 @default.
• W2000956748 cites W1966913075 @default.
• W2000956748 cites W1970659430 @default.
• W2000956748 cites W1974027522 @default.
• W2000956748 cites W1985342306 @default.
• W2000956748 cites W1985927258 @default.
• W2000956748 cites W1988651225 @default.
• W2000956748 cites W2012533901 @default.
• W2000956748 cites W2017204442 @default.
• W2000956748 cites W2022581049 @default.
• W2000956748 cites W2031974543 @default.
• W2000956748 cites W2036529729 @default.
• W2000956748 cites W2041923673 @default.
• W2000956748 cites W2050868896 @default.
• W2000956748 cites W2066212503 @default.
• W2000956748 cites W2069966111 @default.
• W2000956748 cites W2087833681 @default.
• W2000956748 cites W2090240581 @default.
• W2000956748 cites W2090725173 @default.
• W2000956748 cites W2093085618 @default.
• W2000956748 cites W2129419344 @default.
• W2000956748 cites W2149053827 @default.
• W2000956748 cites W2159836554 @default.
• W2000956748 cites W2297600740 @default.
• W2000956748 cites W2333534168 @default.
• W2000956748 cites W2412520094 @default.
• W2000956748 cites W2432466048 @default.
• W2000956748 cites W4229972613 @default.
• W2000956748 cites W4233622640 @default.
• W2000956748 cites W4237281551 @default.
• W2000956748 doi "https://doi.org/10.1046/j.1523-1755.1999.00419.x" @default.
• W2000956748 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10231445" @default.
• W2000956748 hasPublicationYear "1999" @default.
• W2000956748 type Work @default.
• W2000956748 sameAs 2000956748 @default.
• W2000956748 citedByCount "20" @default.
• W2000956748 countsByYear W20009567482012 @default.
• W2000956748 countsByYear W20009567482013 @default.
• W2000956748 countsByYear W20009567482014 @default.
• W2000956748 countsByYear W20009567482016 @default.
• W2000956748 countsByYear W20009567482017 @default.
• W2000956748 countsByYear W20009567482020 @default.
• W2000956748 crossrefType "journal-article" @default.
• W2000956748 hasAuthorship W2000956748A5035803024 @default.
• W2000956748 hasAuthorship W2000956748A5055901854 @default.
• W2000956748 hasAuthorship W2000956748A5062672488 @default.
• W2000956748 hasAuthorship W2000956748A5062819532 @default.
• W2000956748 hasAuthorship W2000956748A5064722554 @default.
• W2000956748 hasBestOaLocation W20009567481 @default.
• W2000956748 hasConcept C10146269 @default.
• W2000956748 hasConcept C126322002 @default.
• W2000956748 hasConcept C130316041 @default.
• W2000956748 hasConcept C134018914 @default.
• W2000956748 hasConcept C161457703 @default.
• W2000956748 hasConcept C178790620 @default.
• W2000956748 hasConcept C185592680 @default.
• W2000956748 hasConcept C188053792 @default.
• W2000956748 hasConcept C2780091579 @default.
• W2000956748 hasConcept C41625074 @default.
• W2000956748 hasConcept C537181965 @default.
• W2000956748 hasConcept C5426402 @default.
• W2000956748 hasConcept C55493867 @default.
• W2000956748 hasConcept C71924100 @default.
• W2000956748 hasConcept C86803240 @default.
• W2000956748 hasConceptScore W2000956748C10146269 @default.
• W2000956748 hasConceptScore W2000956748C126322002 @default.
• W2000956748 hasConceptScore W2000956748C130316041 @default.
• W2000956748 hasConceptScore W2000956748C134018914 @default.
• W2000956748 hasConceptScore W2000956748C161457703 @default.
• W2000956748 hasConceptScore W2000956748C178790620 @default.
• W2000956748 hasConceptScore W2000956748C185592680 @default.
• W2000956748 hasConceptScore W2000956748C188053792 @default.
• W2000956748 hasConceptScore W2000956748C2780091579 @default.
• W2000956748 hasConceptScore W2000956748C41625074 @default.
• W2000956748 hasConceptScore W2000956748C537181965 @default.
• W2000956748 hasConceptScore W2000956748C5426402 @default.
• W2000956748 hasConceptScore W2000956748C55493867 @default.
• W2000956748 hasConceptScore W2000956748C71924100 @default.
• W2000956748 hasConceptScore W2000956748C86803240 @default.
• W2000956748 hasIssue "5" @default.
• W2000956748 hasLocation W20009567481 @default.
• W2000956748 hasLocation W20009567482 @default.

• next